Postural stability in blepharospasm: the effects of dual-tasking and botulinum toxin therapy.
botulinum toxin
dystonia
movement disorders
Journal
BMJ neurology open
ISSN: 2632-6140
Titre abrégé: BMJ Neurol Open
Pays: England
ID NLM: 101775450
Informations de publication
Date de publication:
2023
2023
Historique:
received:
02
01
2023
accepted:
01
03
2023
entrez:
15
3
2023
pubmed:
16
3
2023
medline:
16
3
2023
Statut:
epublish
Résumé
Blepharospasm is a focal dystonia that presents as involuntary, intermittent, continuous contractions of the eyelids. Abnormal eyelid contractions in blepharospasm are expected to cause balance problems, but there is no clear information. This study was designed to evaluate the effect of blepharospasm on postural stability (PS) in patients with blepharospasm. As a secondary endpoint, the efficacy of botulinum toxin type-A (BoNT-A) treatment on static balance in patients with blepharospasm was investigated. Twenty-four patients with blepharospasm receiving regular BoNT-A injections and 20 age-matched and sex-matched healthy controls were included in the study. All subjects were evaluated on a static posturography force platform performing four tasks (eyes open (EO), eyes closed (EC), tandem Romberg (TR) and verbal cognitive task (COGT)). Evaluations of the patients were repeated 4 weeks after the injection. Pretreatment lateral and anterior-posterior sways, sway area and velocities of the sways were significantly higher in patients than controls during the COGT and TR (p<0.05). In the patient group, with EO and EC, a few parameters improved after BoNT-A injection. On the other hand, in the TR and COGT, most of the sway parameters and velocities improved significantly after treatment (p<0.05). Blepharospasm may cause functional blindness in patients. This study demonstrated that PS worsens in patients with blepharospasm under dual-task conditions. BoNT-A injection treats the disease itself and, thus, markedly improves PS under dual-task conditions in blepharospasm.
Sections du résumé
Background
UNASSIGNED
Blepharospasm is a focal dystonia that presents as involuntary, intermittent, continuous contractions of the eyelids. Abnormal eyelid contractions in blepharospasm are expected to cause balance problems, but there is no clear information.
Objective
UNASSIGNED
This study was designed to evaluate the effect of blepharospasm on postural stability (PS) in patients with blepharospasm. As a secondary endpoint, the efficacy of botulinum toxin type-A (BoNT-A) treatment on static balance in patients with blepharospasm was investigated.
Methods
UNASSIGNED
Twenty-four patients with blepharospasm receiving regular BoNT-A injections and 20 age-matched and sex-matched healthy controls were included in the study. All subjects were evaluated on a static posturography force platform performing four tasks (eyes open (EO), eyes closed (EC), tandem Romberg (TR) and verbal cognitive task (COGT)). Evaluations of the patients were repeated 4 weeks after the injection.
Results
UNASSIGNED
Pretreatment lateral and anterior-posterior sways, sway area and velocities of the sways were significantly higher in patients than controls during the COGT and TR (p<0.05). In the patient group, with EO and EC, a few parameters improved after BoNT-A injection. On the other hand, in the TR and COGT, most of the sway parameters and velocities improved significantly after treatment (p<0.05).
Conclusions
UNASSIGNED
Blepharospasm may cause functional blindness in patients. This study demonstrated that PS worsens in patients with blepharospasm under dual-task conditions. BoNT-A injection treats the disease itself and, thus, markedly improves PS under dual-task conditions in blepharospasm.
Identifiants
pubmed: 36919159
doi: 10.1136/bmjno-2023-000403
pii: bmjno-2023-000403
pmc: PMC10008225
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e000403Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Eur Neurol. 2002;48(1):26-9
pubmed: 12138306
Gait Posture. 2011 Mar;33(3):401-5
pubmed: 21251833
Man Ther. 2006 May;11(2):99-106
pubmed: 15919229
Parkinsonism Relat Disord. 2005 Mar;11(2):95-9
pubmed: 15734667
Biosci Hypotheses. 2008;1(1):14-25
pubmed: 19180244
JAMA. 1982 Dec 17;248(23):3160-4
pubmed: 7143695
Phys Ther. 2010 Feb;90(2):177-86
pubmed: 20023000
Int Ophthalmol Clin. 2018 Winter;58(1):11-24
pubmed: 29239874
Psychol Sci. 2001 May;12(3):230-7
pubmed: 11437306
Korean J Ophthalmol. 2018 Feb;32(1):1-7
pubmed: 29376224
J Gerontol B Psychol Sci Soc Sci. 2009 Mar;64(2):193-201
pubmed: 19255088
Sci Rep. 2017 Jun 22;7(1):4070
pubmed: 28642466
Neurorehabil Neural Repair. 2018 Feb;32(2):166-174
pubmed: 29554851
Psychol Bull. 1994 Sep;116(2):220-44
pubmed: 7972591
J Athl Train. 2007 Jan-Mar;42(1):42-6
pubmed: 17597942
Arch Phys Med Rehabil. 2007 Jan;88(1):50-3
pubmed: 17207675
J Gerontol A Biol Sci Med Sci. 2002 Dec;57(12):M785-92
pubmed: 12456737
Arq Neuropsiquiatr. 2020 Sep;78(9):549-555
pubmed: 32609289
Exp Brain Res. 2018 Mar;236(3):803-811
pubmed: 29340715
Mov Disord. 2007 Mar 15;22(4):498-503
pubmed: 17226858
Neuroimage. 2008 May 1;40(4):1772-81
pubmed: 18329904
Mov Disord. 2013 Jun 15;28(7):863-73
pubmed: 23649720
Mov Disord. 2012 Dec;27(14):1789-96
pubmed: 23114997
Exp Brain Res. 2008 May;187(2):275-81
pubmed: 18273609
Am J Geriatr Psychiatry. 2006 Jan;14(1):52-61
pubmed: 16407582